Pituitary tumor cosecreting thyrotropin and prolactin causing hyperthyroidism--a case report.
We report a case of a pituitary tumor cosecreting thyrotropin and prolactin with clinical manifestation of thyrotoxicosis, which is a very rare clinical disorder. Octreotide therapy is effective in suppressing the secretion of thyrotropin, prolactin, and thyroid hormones, and by this, renders relief of symptoms and complications of thyrotoxicosis.
Song
Y M
YM
Department of Medicine, Taichung Veterans General Hospital, Taiwan.
Sheu
W H
WH
D000236:Adenoma / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D013971:Thyrotoxicosis / Q000209:etiology; D013972:Thyrotropin / Q000378:metabolism*
D011388:Prolactin; D013972:Thyrotropin; D015282:Octreotide